A Path to Preventing Cognitive Impairment Due to Alzheimer Disease

April 13
28 mins

View Transcript

Episode Description

Dr. Greg Cooper talks with Dr. Eric Reiman about emerging antibody therapies for preclinical Alzheimer disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.

Read the related article in The Lancet Neurology. 

Disclosures can be found at Neurology.org

See all episodes